http://www.nytimes.com/2017/03/01/health/patient-groups-drug-industry-money.html?partner=rss&emc=rss
About 80 percent of the top advocacy organizations received funds from industry sources, and sometimes failed to disclose their ties publicly.
http://www.nytimes.com/2017/03/01/health/patient-groups-drug-industry-money.html?partner=rss&emc=rss
About 80 percent of the top advocacy organizations received funds from industry sources, and sometimes failed to disclose their ties publicly.